# Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH

> **NCT00267670** · PHASE2,PHASE3 · COMPLETED · sponsor: **Northwestern University** · enrollment: 26 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis
- Liver Diseases

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00267670
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267670, "Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00267670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*